Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

Ronja Hietikko; Tuomas P. Kilpeläinen; Anu Kenttämies; Johanna Ronkainen; Kirsty Ijäs; Kati Lind; Suvi Marjasuo; Juha Oksala; Outi Oksanen; Tuomas Saarinen; Ritja Savolainen; Kimmo Taari; Teuvo L. J. Tammela; Tuomas Mirtti; Kari Natunen; Anssi Auvinen; Antti Rannikko

doi:10.1186/s40644-020-00351-w

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

Ronja Hietikko, Tuomas P. Kilpeläinen, Anu Kenttämies, Johanna Ronkainen, Kirsty Ijäs, Kati Lind, Suvi Marjasuo, Juha Oksala, Outi Oksanen, Tuomas Saarinen, Ritja Savolainen, Kimmo Taari, Teuvo L. J. Tammela, Tuomas Mirtti, Kari Natunen, Anssi Auvinen, Antti Rannikko

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	72
Journal	Cancer imaging
Volume	20
Issue number	1
Number of pages	8
ISSN	1470-7330
DOIs	https://doi.org/10.1186/s40644-020-00351-w
Publication status	Published - 9 Oct 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

3122 Cancers
Prostate cancer
Agreement
Magnetic resonance imaging
PI-RADS version 2
Screening
GUIDELINES
DIAGNOSIS
ACCURACY
BIOPSY

Access to Document

10.1186/s40644-020-00351-w

Hietikko2020_Article_ExpectedImpactOfMRI-relatedIntFinal published version, 837 KBLicence: CC BY

Cite this

Hietikko, R., Kilpeläinen, T. P., Kenttämies, A., Ronkainen, J., Ijäs, K., Lind, K., Marjasuo, S., Oksala, J., Oksanen, O., Saarinen, T., Savolainen, R., Taari, K., Tammela, T. L. J., Mirtti, T., Natunen, K., Auvinen, A., & Rannikko, A. (2020). Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study. Cancer imaging, 20(1), Article 72. https://doi.org/10.1186/s40644-020-00351-w

@article{4daeb0a708d142e6b0b0af3ebd58fca4,

title = "Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study",

keywords = "3122 Cancers, Prostate cancer, Agreement, Magnetic resonance imaging, PI-RADS version 2, Screening, GUIDELINES, DIAGNOSIS, ACCURACY, BIOPSY",

author = "Ronja Hietikko and Kilpel{\"a}inen, {Tuomas P.} and Anu Kentt{\"a}mies and Johanna Ronkainen and Kirsty Ij{\"a}s and Kati Lind and Suvi Marjasuo and Juha Oksala and Outi Oksanen and Tuomas Saarinen and Ritja Savolainen and Kimmo Taari and Tammela, {Teuvo L. J.} and Tuomas Mirtti and Kari Natunen and Anssi Auvinen and Antti Rannikko",

year = "2020",

month = oct,

day = "9",

doi = "10.1186/s40644-020-00351-w",

language = "English",

volume = "20",

journal = "Cancer imaging",

issn = "1470-7330",

publisher = "E-MED LIMITED",

number = "1",

}

Hietikko, R, Kilpeläinen, TP , Kenttämies, A, Ronkainen, J, Ijäs, K, Lind, K, Marjasuo, S, Oksala, J, Oksanen, O, Saarinen, T, Savolainen, R, Taari, K, Tammela, TLJ, Mirtti, T, Natunen, K, Auvinen, A & Rannikko, A 2020, 'Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study', Cancer imaging, vol. 20, no. 1, 72. https://doi.org/10.1186/s40644-020-00351-w

TY - JOUR

T1 - Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

AU - Hietikko, Ronja

AU - Kilpeläinen, Tuomas P.

AU - Kenttämies, Anu

AU - Ronkainen, Johanna

AU - Ijäs, Kirsty

AU - Lind, Kati

AU - Marjasuo, Suvi

AU - Oksala, Juha

AU - Oksanen, Outi

AU - Saarinen, Tuomas

AU - Savolainen, Ritja

AU - Taari, Kimmo

AU - Tammela, Teuvo L. J.

AU - Mirtti, Tuomas

AU - Natunen, Kari

AU - Auvinen, Anssi

AU - Rannikko, Antti

PY - 2020/10/9

Y1 - 2020/10/9

KW - 3122 Cancers

KW - Prostate cancer

KW - Agreement

KW - Magnetic resonance imaging

KW - PI-RADS version 2

KW - Screening

KW - GUIDELINES

KW - DIAGNOSIS

KW - ACCURACY

KW - BIOPSY

U2 - 10.1186/s40644-020-00351-w

DO - 10.1186/s40644-020-00351-w

M3 - Article

SN - 1470-7330

VL - 20

JO - Cancer imaging

JF - Cancer imaging

IS - 1

M1 - 72

ER -